| BNOUnderwritten Rights Issue to Raise $16.4 Million |
| 04/03/13 | PRICE SENSITIVE | | Share |
|
| BNOTrading Halt |
| 28/02/13 | PRICE SENSITIVE | | Share |
|
| BNOHalf Yearly Report and Accounts |
| 14/02/13 | PRICE SENSITIVE | | Share |
|
| BNOBNO Provides BNC101 Update at US Cancer Stem Cell Conference |
| 11/02/13 | PRICE SENSITIVE | | Share |
|
| BNOBNC375 Alzheimer's Disease Data Presented at Conference |
| 04/02/13 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 31/01/13 | PRICE SENSITIVE | | Share |
|
| BNOBionomics R&D Tax Incentive for FY2012 |
| 15/01/13 | PRICE SENSITIVE | | Share |
|
| BNOCEO Update and US Investor Presentation |
| 09/01/13 | PRICE SENSITIVE | | Share |
|
| BNOBNC210 US TRIAL |
| 21/12/12 | PRICE SENSITIVE | | Share |
|
| BNOBionomics New Alzheimer's Drug Candidate |
| 14/12/12 | PRICE SENSITIVE | | Share |
|
| BNOCEO & Managing Director AGM Presentation 2012 |
| 14/11/12 | PRICE SENSITIVE | | Share |
|
| BNOIND Submission to FDA for BNC210 Anti-Anxiety Drug Candidate |
| 08/11/12 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 31/10/12 | PRICE SENSITIVE | | Share |
|
| BNOALPHA 7 PROGRAM TO BE SHOWCASED AT NEUROSCIENCE 2012 |
| 16/10/12 | PRICE SENSITIVE | | Share |
|
| BNOBionomics Acquires US-Based Cancer Stem Cell Company |
| 17/09/12 | PRICE SENSITIVE | | Share |
|
| BNOFDA Approval for Ironwood |
| 31/08/12 | PRICE SENSITIVE | | Share |
|
| BNOBionomics' 2011/2012 Preliminary Final Results |
| 15/08/12 | PRICE SENSITIVE | | Share |
|
| BNOBionomics Secures Key US Patent for VDA BNC105 |
| 15/08/12 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 30/07/12 | PRICE SENSITIVE | | Share |
|
| BNOOpen Briefing - CEO on Kv1.3 Program and Outlook |
| 27/06/12 | PRICE SENSITIVE | | Share |
|
| BNOUS Patent Granted for Kv1.3 Program |
| 26/06/12 | PRICE SENSITIVE | | Share |
|
| BNOBionomics to Expand KV1.3 Program |
| 15/06/12 | PRICE SENSITIVE | | Share |
|
| BNOBNC105 Trial Data Presented at ASCO |
| 01/06/12 | PRICE SENSITIVE | | Share |
|
| BNOBionomics Launches BNC105 Ovarian Cancer Trial |
| 24/05/12 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 30/04/12 | PRICE SENSITIVE | | Share |
|
| BNOOpen Briefing - CEO on BNC105 Ovarian Cancer Trial |
| 03/04/12 | PRICE SENSITIVE | | Share |
|
| BNOBNC105 Ovarian Cancer Progress |
| 02/04/12 | PRICE SENSITIVE | | Share |
|
| BNOBNC105 Ovarian Cancer Trial Approved |
| 23/03/12 | PRICE SENSITIVE | | Share |
|
| BNOBionomics Targets Alzheimer's Disease |
| 16/02/12 | PRICE SENSITIVE | | Share |
|
| BNOHalf Yearly Report and Accounts |
| 14/02/12 | PRICE SENSITIVE | | Share |
|
| BNOBNC105 Renal Cancer Trial Data Presented at ASCO-GU |
| 03/02/12 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 31/01/12 | PRICE SENSITIVE | | Share |
|
| BNOIronwood and Bionomics Announce Agreement |
| 05/01/12 | PRICE SENSITIVE | | Share |
|
| BNOTrading Halt |
| 04/01/12 | PRICE SENSITIVE | | Share |
|
| BNOBNC210 Clinical Data Presented at Neuroscience 2011 |
| 15/11/11 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 28/10/11 | PRICE SENSITIVE | | Share |
|
| BNOBNC105 Renal Cancer Trial Update |
| 20/09/11 | PRICE SENSITIVE | | Share |
|
| BNOBionomics' 2010/2011 Preliminary Final Results |
| 18/08/11 | PRICE SENSITIVE | | Share |
|
| BNOBNC105 Clinical Trials Reach Key Milestones |
| 03/08/11 | PRICE SENSITIVE | | Share |
|
| BNOTrading Halt |
| 01/08/11 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 29/07/11 | PRICE SENSITIVE | | Share |
|
| BNOPhase I BNC105 Clinical Trial Published |
| 23/06/11 | PRICE SENSITIVE | | Share |
|
| BNOMerck Serono Extends MS Collaboration with Bionomics |
| 09/06/11 | PRICE SENSITIVE | | Share |
|
| BNOBNC105 Renal Cancer Trial To Be Presented AT ASCO |
| 03/06/11 | PRICE SENSITIVE | | Share |
|
| BNOOpen Briefing - Outlook and Strategic Focus |
| 25/05/11 | PRICE SENSITIVE | | Share |
|
| BNOSuccessful Register Repositioning Complete |
| 13/05/11 | PRICE SENSITIVE | | Share |
|
| BNOTrading Halt |
| 12/05/11 | PRICE SENSITIVE | | Share |
|
| BNOStart-up Australia Ventures Sells 60 Millions BNO Shares |
| 12/05/11 | PRICE SENSITIVE | | Share |
|
| BNOBNC210 - Further Validation |
| 10/05/11 | PRICE SENSITIVE | | Share |
|
| BNOBNO Sells Thebarton Premises to Boost Cash Reserves |
| 04/05/11 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 29/04/11 | PRICE SENSITIVE | | Share |
|
| BNOResponse to ASX Price Query |
| 13/04/11 | PRICE SENSITIVE | | Share |
|
| BNOInvitation to Tender for Shares |
| 30/03/11 | PRICE SENSITIVE | | Share |
|
| BNOAnti-Anxiety Drug Clinical Trials Successful Results |
| 30/03/11 | PRICE SENSITIVE | | Share |
|
| BNOTrading Halt |
| 28/03/11 | PRICE SENSITIVE | | Share |
|
| BNOHalf Yearly Report and Accounts |
| 11/02/11 | PRICE SENSITIVE | | Share |
|
| BNOPatent Applications Filed on Compounds to Treat Memory Loss |
| 04/02/11 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 31/01/11 | PRICE SENSITIVE | | Share |
|
| BNOOpen Briefing - CEO on Company Update and BNC210 Results |
| 25/11/10 | PRICE SENSITIVE | | Share |
|
| BNOInvitation to tender for the purchase of 27.76% of shares |
| 10/11/10 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 27/10/10 | PRICE SENSITIVE | | Share |
|
| BNOBNC210 - European Approval Granted for Two Phase Ib Trials |
| 05/10/10 | PRICE SENSITIVE | | Share |
|
| BNOOpen Briefing - BNO CEO on BNC210 Clinical Trials |
| 02/09/10 | PRICE SENSITIVE | | Share |
|
| BNOBNC210 Data Presented at Leading European Forum |
| 30/08/10 | PRICE SENSITIVE | | Share |
|
| BNOFull Year Statutory Accounts |
| 19/08/10 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 19/07/10 | PRICE SENSITIVE | | Share |
|
| BNOBNC210 Phase I Trial Successful |
| 21/06/10 | PRICE SENSITIVE | | Share |
|
| BNOBionomics Presents BNC105 Clinical Data at ASCO |
| 07/06/10 | PRICE SENSITIVE | | Share |
|
| BNOOpen Briefing - CEO on Merck Serono Extension |
| 25/05/10 | PRICE SENSITIVE | | Share |
|
| BNOMerck Serono Agreement Extended |
| 24/05/10 | PRICE SENSITIVE | | Share |
|
| BNOSecond BNC210 Phase I Clinical Trial Commences |
| 06/05/10 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 21/04/10 | PRICE SENSITIVE | | Share |
|
| BNONew BNC105 Data Presented at International Cancer Conference |
| 16/04/10 | PRICE SENSITIVE | | Share |
|
| BNOOpen Briefing - CEO on Clinical Trials Update |
| 31/03/10 | PRICE SENSITIVE | | Share |
|
| BNOBNC105 Phase II Mesothelioma Clinical Trial Starts |
| 26/03/10 | PRICE SENSITIVE | | Share |
|
| BNOBNC210 Clinical Trial Results |
| 02/03/10 | PRICE SENSITIVE | | Share |
|
| BNOHalf Yearly Report and Accounts |
| 18/02/10 | PRICE SENSITIVE | | Share |
|
| BNOPositive New BNC210 Data |
| 02/02/10 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 28/01/10 | PRICE SENSITIVE | | Share |
|
| BNOBNC105 US Renal Cancer Trial Initiated |
| 27/01/10 | PRICE SENSITIVE | | Share |
|
| BNOOpen Briefing - BNC105 Phase II Trial for Mesothelioma |
| 22/12/09 | PRICE SENSITIVE | | Share |
|
| BNOBNO to Conduct Phase II Trial in Mesothelioma |
| 09/12/09 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 29/10/09 | PRICE SENSITIVE | | Share |
|
| BNOFirst Stage of BNC210 Clinical Trial Successfully Completed |
| 27/10/09 | PRICE SENSITIVE | | Share |
|
| BNOLatest BNC210 Data To Be Presented In US |
| 16/10/09 | PRICE SENSITIVE | | Share |
|
| BNOCEO Open Briefing |
| 17/09/09 | PRICE SENSITIVE | | Share |
|
| BNOReinstatement to Official Quotation |
| 08/09/09 | PRICE SENSITIVE | | Share |
|
| BNO$15 Million Capital Raising |
| 08/09/09 | PRICE SENSITIVE | | Share |
|
| BNOSuspension from Official Quotation |
| 07/09/09 | PRICE SENSITIVE | | Share |
|
| BNOTrading Halt |
| 03/09/09 | PRICE SENSITIVE | | Share |
|
| BNOPreliminary Final Report - Appendix 4E |
| 28/08/09 | PRICE SENSITIVE | | Share |
|
| BNOAppendix 4C - quarterly |
| 29/07/09 | PRICE SENSITIVE | | Share |
|
| BNOOpen Briefing - BNO CEO on Milestones Achieved |
| 02/07/09 | PRICE SENSITIVE | | Share |
|
| BNOBNO - US Clinical Trial of BNC105 in Renal Cell Cancer |
| 02/07/09 | PRICE SENSITIVE | | Share |
|
| BNOBNC210 Phase I Clinical Trial Initiated |
| 25/06/09 | PRICE SENSITIVE | | Share |
|
| BNOOpen Briefing BNC105 Interim Data |
| 29/05/09 | PRICE SENSITIVE | | Share |
|
| BNOInitial Data from BNC105 Phase I Clinical Trial Presented |
| 29/05/09 | PRICE SENSITIVE | | Share |
|
| BNOBNO Anxiety Drug Candidate Approved to Enter Human Trial |
| 21/05/09 | PRICE SENSITIVE | | Share |
|
| BNOOpen Briefing - New Data on BNC105 |
| 22/04/09 | PRICE SENSITIVE | | Share |
|
| BNONew BNC105 Data Presented at AACR Conference |
| 22/04/09 | PRICE SENSITIVE | | Share |
|
